Search

Laura K. Tso

Examiner (ID: 1977, Phone: (571)272-2385 , Office: P/2875 )

Most Active Art Unit
2875
Art Unit(s)
2875, 3303, 3302, 2109, 2831, 2103
Total Applications
3051
Issued Applications
2669
Pending Applications
113
Abandoned Applications
284

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6697298 [patent_doc_number] => 20030109492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Non-inclusion cyclodextrin complexes' [patent_app_type] => new [patent_app_number] => 10/272936 [patent_app_country] => US [patent_app_date] => 2002-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12889 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109492.pdf [firstpage_image] =>[orig_patent_app_number] => 10272936 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/272936
Non-inclusion cyclodextrin complexes Oct 17, 2002 Issued
Array ( [id] => 6652233 [patent_doc_number] => 20030105165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Gap junctions and EDHF' [patent_app_type] => new [patent_app_number] => 10/270663 [patent_app_country] => US [patent_app_date] => 2002-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9558 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105165.pdf [firstpage_image] =>[orig_patent_app_number] => 10270663 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/270663
Gap junctions and EDHF Oct 15, 2002 Abandoned
Array ( [id] => 720607 [patent_doc_number] => 07049436 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-23 [patent_title] => 'Carbon dioxide compatible non-aqueous crosslinked fracturing fluids and methods for their use' [patent_app_type] => utility [patent_app_number] => 10/267686 [patent_app_country] => US [patent_app_date] => 2002-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 4874 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/049/07049436.pdf [firstpage_image] =>[orig_patent_app_number] => 10267686 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/267686
Carbon dioxide compatible non-aqueous crosslinked fracturing fluids and methods for their use Oct 8, 2002 Issued
Array ( [id] => 6822109 [patent_doc_number] => 20030220270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Mono-and disaccharide derivatives' [patent_app_type] => new [patent_app_number] => 10/148441 [patent_app_country] => US [patent_app_date] => 2002-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 26737 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220270.pdf [firstpage_image] =>[orig_patent_app_number] => 10148441 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/148441
Mono-and disaccharide derivatives Oct 6, 2002 Abandoned
Array ( [id] => 6678908 [patent_doc_number] => 20030229049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Method and pharmaceutical to treat spinal discs' [patent_app_type] => new [patent_app_number] => 10/441130 [patent_app_country] => US [patent_app_date] => 2002-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2292 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20030229049.pdf [firstpage_image] =>[orig_patent_app_number] => 10441130 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/441130
Method and pharmaceutical to treat spinal discs Oct 3, 2002 Abandoned
Array ( [id] => 7367109 [patent_doc_number] => 20040006007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Methods and compositions for treating hepatitis C virus using 4\'-modified nucleosides' [patent_app_type] => new [patent_app_number] => 10/261244 [patent_app_country] => US [patent_app_date] => 2002-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 31547 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 63 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20040006007.pdf [firstpage_image] =>[orig_patent_app_number] => 10261244 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/261244
Methods and compositions for treating hepatitis C virus using 4'-modified nucleosides Sep 29, 2002 Issued
Array ( [id] => 1080677 [patent_doc_number] => 06835720 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-12-28 [patent_title] => 'Compounds having antiviral activity' [patent_app_type] => B2 [patent_app_number] => 10/252036 [patent_app_country] => US [patent_app_date] => 2002-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 17 [patent_no_of_words] => 20400 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/835/06835720.pdf [firstpage_image] =>[orig_patent_app_number] => 10252036 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/252036
Compounds having antiviral activity Sep 22, 2002 Issued
Array ( [id] => 988265 [patent_doc_number] => 06921820 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-26 [patent_title] => 'Method for forming cellulose' [patent_app_type] => utility [patent_app_number] => 10/247623 [patent_app_country] => US [patent_app_date] => 2002-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 6787 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/921/06921820.pdf [firstpage_image] =>[orig_patent_app_number] => 10247623 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/247623
Method for forming cellulose Sep 19, 2002 Issued
Array ( [id] => 6818249 [patent_doc_number] => 20030069207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administration' [patent_app_type] => new [patent_app_number] => 10/237918 [patent_app_country] => US [patent_app_date] => 2002-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2808 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20030069207.pdf [firstpage_image] =>[orig_patent_app_number] => 10237918 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/237918
Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administration Sep 8, 2002 Issued
Array ( [id] => 6852032 [patent_doc_number] => 20030144235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => '4\'-thio-L-xylofuranosyl nucleosides, precursors thereof, preparation and use thereof' [patent_app_type] => new [patent_app_number] => 10/237192 [patent_app_country] => US [patent_app_date] => 2002-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5136 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144235.pdf [firstpage_image] =>[orig_patent_app_number] => 10237192 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/237192
4′-thio-L-xylofuranosyl nucleosides, precursors thereof, preparation and use thereof Sep 8, 2002 Issued
Array ( [id] => 6792743 [patent_doc_number] => 20030088087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Synthesis, deprotection, analysis & purification of RNA & ribozymes' [patent_app_type] => new [patent_app_number] => 10/231874 [patent_app_country] => US [patent_app_date] => 2002-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 12018 [patent_no_of_claims] => 127 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20030088087.pdf [firstpage_image] =>[orig_patent_app_number] => 10231874 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/231874
Synthesis, deprotection, analysis and purification of RNA and ribozymes Aug 29, 2002 Issued
Array ( [id] => 6716577 [patent_doc_number] => 20030027925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Oligosaccharide synthesis' [patent_app_type] => new [patent_app_number] => 10/231909 [patent_app_country] => US [patent_app_date] => 2002-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12130 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027925.pdf [firstpage_image] =>[orig_patent_app_number] => 10231909 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/231909
Oligosaccharide synthesis Aug 29, 2002 Issued
Array ( [id] => 6711824 [patent_doc_number] => 20030171573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Multivalently interactive molecular assembly, capturing agent, drug carrier, calcium chelating agent, and drug enhancer' [patent_app_type] => new [patent_app_number] => 10/230394 [patent_app_country] => US [patent_app_date] => 2002-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13634 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20030171573.pdf [firstpage_image] =>[orig_patent_app_number] => 10230394 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/230394
Multivalently interactive molecular assembly, capturing agent, drug carrier, calcium chelating agent, and drug enhancer Aug 28, 2002 Abandoned
Array ( [id] => 6651219 [patent_doc_number] => 20030105029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Drugs, foods or drinks with the use of algae-derived physiologically active substances' [patent_app_type] => new [patent_app_number] => 10/228195 [patent_app_country] => US [patent_app_date] => 2002-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 28529 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105029.pdf [firstpage_image] =>[orig_patent_app_number] => 10228195 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/228195
Drugs, foods or drinks with the use of algae-derived physiologically active substances Aug 26, 2002 Issued
Array ( [id] => 6783506 [patent_doc_number] => 20030064954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'Cationic amphiphilic 1,4-dihydropyridine derivatives useful for delivery of nucleotide containing compounds' [patent_app_type] => new [patent_app_number] => 10/204640 [patent_app_country] => US [patent_app_date] => 2002-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19725 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20030064954.pdf [firstpage_image] =>[orig_patent_app_number] => 10204640 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/204640
Cationic amphiphilic 1,4-dihydropyridine derivatives useful for delivery of nucleotide containing compounds Aug 21, 2002 Abandoned
Array ( [id] => 1025188 [patent_doc_number] => 06884880 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-04-26 [patent_title] => 'Process for the preparation of 9-β-anomeric nucleoside analogs' [patent_app_type] => utility [patent_app_number] => 10/225032 [patent_app_country] => US [patent_app_date] => 2002-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6499 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/884/06884880.pdf [firstpage_image] =>[orig_patent_app_number] => 10225032 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/225032
Process for the preparation of 9-β-anomeric nucleoside analogs Aug 20, 2002 Issued
Array ( [id] => 6628678 [patent_doc_number] => 20030005857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Saccharide compound and a method of producing the same' [patent_app_type] => new [patent_app_number] => 10/223364 [patent_app_country] => US [patent_app_date] => 2002-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7364 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20030005857.pdf [firstpage_image] =>[orig_patent_app_number] => 10223364 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/223364
Saccharide compound and a method of producing the same Aug 19, 2002 Abandoned
Array ( [id] => 6702152 [patent_doc_number] => 20030225032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Pharmaceutical composition' [patent_app_type] => new [patent_app_number] => 10/217551 [patent_app_country] => US [patent_app_date] => 2002-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2135 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20030225032.pdf [firstpage_image] =>[orig_patent_app_number] => 10217551 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/217551
Pharmaceutical composition Aug 13, 2002 Issued
Array ( [id] => 6658047 [patent_doc_number] => 20030078232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Adenosine receptor A3 agonists' [patent_app_type] => new [patent_app_number] => 10/212896 [patent_app_country] => US [patent_app_date] => 2002-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13859 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20030078232.pdf [firstpage_image] =>[orig_patent_app_number] => 10212896 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/212896
Adenosine receptor A3 agonists Aug 4, 2002 Abandoned
Array ( [id] => 7674665 [patent_doc_number] => 20040127453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Method for treating diseases associated with abnormal kinase activity' [patent_app_type] => new [patent_app_number] => 10/206854 [patent_app_country] => US [patent_app_date] => 2002-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15707 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127453.pdf [firstpage_image] =>[orig_patent_app_number] => 10206854 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/206854
Method for treating diseases associated with abnormal kinase activity Jul 25, 2002 Issued
Menu